Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Psoriasis
Psoriasis News
Risankizumab Effective in Moderate-to-Severe Plaque PsoriasisRisankizumab, a monoclonal antibody that binds to the p19 subunit of interleukin-23, is effective for treating moderate-to-severe plaque psoriasis, according to results from two phase 3 trials.
Reuters Health Information, August 20, 2018
Adalimumab Appears Safe for Treating Pediatric Patients With Autoimmune DiseaseAdalimumab appears to be safe for treating pediatric patients with polyarticular juvenile idiopathic arthritis (JIA), enthesitis-related arthritis (ERA), psoriasis and Crohn's disease (CD), according to data from company-sponsored clinical trials.
Hyperhidrosis: Five Things to KnowPublic awareness of this medical condition is driving many patients out of the woodwork and into their provider's offices. Be ready to discuss the treatment options.
Medscape Dermatology, July 27, 2018
AAD 2018Read clinically focused news coverage of key developments from AAD 2018.
